Seemingly disparate conditions such as adolescents who are normal-weight but physically inactive [Reference Ischander, Zaldivar, Eliakim, Nussbaum, Dunton and Leu6], those who exercise at excessive levels [Reference Nemet, Connolly and Pontello-Pescatello7,Reference Javed, Tebben, Fischer and Lteif8], and obese children and adolescents [Reference Petek, Petek, Monik and Varda9], all manifest harmful growth patterns and, often, elevated inflammation associated with increased cardiovascular disease risk
Discard 28 days after first puncture
Physical injury rate (broken bones, wounds, etc) after initiating on GLP-1s vs other medications for T2D or obesity
Unreconstituted Lyophilized Powder : Store at room temperature (18C to 25C / 64F to 77F)